Biomea Fusion, Inc. (BMEA) vs Connect Biopharma Holdings Limited Sponsored ADR (CNTB)

Biomea Fusion, Inc. and Connect Biopharma Holdings Limited Sponsored ADR are both Biotechnology companies. Biomea Fusion, Inc. and Connect Biopharma Holdings Limited Sponsored ADR are of similar size ($60.6M and $57.1M). Biomea Fusion, Inc. has the higher net margin (0.00% vs −2,298.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Biomea Fusion, Inc. leads on 10 and Connect Biopharma Holdings Limited Sponsored ADR on 3.

Valuation

Metric BMEA CNTB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 19.07 9.71
P/B 5.19 2.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 8.64 9.21
Earnings yield (33.33%) (130.77%) (33.15%)
Free cash flow yield (74.51%) (106.62%) (25.50%)

Profitability

Metric BMEA CNTB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (2,346.35%) 0.00%
Net margin 0.00% (2,298.93%) 0.00%
Free cash flow margin 0.00% (2,018.76%) 0.00%
Return on equity (164.14%) (140.51%) (56.36%)
Return on assets (59.14%) (109.34%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BMEA CNTB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 69.19% (257.14%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BMEA CNTB Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 3.48 2.37 4.72
Net debt to EBITDA 0.68 0.77 0.96

Dividend

Metric BMEA CNTB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BMEA CNTB Biotechnology median
Market cap 60.62m 57.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack